Global Longlife Hospital & Research (BOM:543520) EV-to-EBITDA : 8.85 (As of May. 27, 2024)

Global Longlife Hospital & Research EV-to-EBITDA Chart

Competitive Comparison of Global Longlife Hospital & Research's EV-to-EBITDA

For the Medical Care Facilities subindustry, Global Longlife Hospital & Research's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Longlife Hospital & Research's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Global Longlife Hospital & Research's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Global Longlife Hospital & Research's EV-to-EBITDA falls into.

Global Longlife Hospital & Research EV-to-EBITDA Calculation

Global Longlife Hospital & Research's EV-to-EBITDA for today is calculated as:

Global Longlife Hospital & Research's current Enterprise Value is ₹449.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Global Longlife Hospital & Research's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹50.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Longlife Hospital & Research  (BOM:543520) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Global Longlife Hospital & Research's PE Ratio for today is calculated as:

Global Longlife Hospital & Research's share price for today is ₹35.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Global Longlife Hospital & Research's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹2.030.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Global Longlife Hospital & Research EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Global Longlife Hospital & Research's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Longlife Hospital & Research (BOM:543520) Business Description